A systematic approach to the management of patients who refuse medications in an assertive community treatment team setting

Psychiatric Services

Volumn 58, Issue 4, 2007, Pages 457-459

  Tam, Christopher ^a   Law, Samuel ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

CLINICAL PRACTICE; COMMUNITY CARE; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; MEDICAL ETHICS; PATIENT ATTITUDE; PATIENT COMPLIANCE; SCHIZOPHRENIA; SHORT SURVEY; SOCIAL SUPPORT; ARTICLE; AWARENESS; COOPERATION; DOCTOR PATIENT RELATION; ETHICS; EVIDENCE BASED MEDICINE; MENTAL CAPACITY; MENTAL HEALTH SERVICE; PERSUASIVE COMMUNICATION; PROGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PUBLIC RELATIONS; RISK MANAGEMENT; TREATMENT REFUSAL; UNITED STATES; VIOLENCE;

ANTIPSYCHOTIC AGENTS; AWARENESS; COERCION; COMMUNITY MENTAL HEALTH SERVICES; COOPERATIVE BEHAVIOR; DANGEROUS BEHAVIOR; EVIDENCE-BASED MEDICINE; HUMANS; INTERPROFESSIONAL RELATIONS; MENTAL COMPETENCY; PHYSICIAN-PATIENT RELATIONS; PROGNOSIS; RISK MANAGEMENT; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT REFUSAL; UNITED STATES;

EID: 85047695521     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2007.58.4.457     Document Type: Short Survey

References (20)

1. Phillips SD, Burns BJ, Edgar ER, et al: Moving assertive community treatment into standard practice. Psychiatric Services 52:771-779, 2001
2. Dixon L: Assertive community treatment: twenty-five years of gold. Psychiatric Services 51:759-765, 2000
3. Lacro JP, Dunn LB, Dolder CR, et al: Prevalence of and risk factors for medication non-adherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63:892-909, 2002
4. Perkins DO: Predictors of noncompliance in patients with schizophrenia. Journal of Clinical Psychiatry 63:1121-1128, 2002
5. Dixon LB, Krauss N, Kernan E, et al: Modifying the PACT model to serve homeless persons with severe mental illness. Psychiatric Services 46:684-688, 1995
6. Grisso T, Appelbaum PS: The MacArthur treatment competence study. III: abilities of patients to consent to psychiatric and medical treatments. Law and Human Behavior 19: 149-174, 1995
7. Bay M, Fram S, Silberfeld M, et al: Capacity and substitute decision making for personal care, in A Practical Guide to Mental Health, Capacity, and Consent Law of Ontario. Edited by Bloom H, Bay M. Toronto, Carswell Thomson Professional Publishing, 1996
8. Gilbert PL, Harris MJ, McAdams LA, et al: Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry 52: 173-188, 1995
9. Amador XF, Flaum M, Andreasen NC, et al: Awareness of illness in schizophrenia and schizoaffective and mood disorders. Archives of General Psychiatry 51:826-836, 1994
10. Hackman A, Dixon L: Assertive community treatment, in Clinical Guide to the Treatment of the Mentally Ill Homeless Person. Edited by Gillig PM, McQuistion HL. Washington, DC, American Psychiatric Publishing, 2006
11. Nuechterlein KH, Gitlin MJ, Subotnik KL: The early course of schizophrenia and long-term maintenance neuroleptic therapy. Archives of General Psychiatry 52:203-205, 1995
12. Szymanski SR, Cannon TD, Gallacher F, et al: Course of treatment response in first-episode and chronic schizophrenia. American Journal of Psychiatry 153:519-525, 1996
13. Stern RG, Kahn RS, Davidson M: Predictors of response to neuroleptic treatment in schizophrenia. Psychiatric Clinics of North America 16:313-338, 1993
14. Awad AG, Voruganti LNP, Heslegrave RJ: The aims of antipsychotic medication: what are they and are they being achieved? CNS Drugs 4:8-16, 1995
15. Meltzer HY: Neuroleptic withdrawal in schizophrenic patients: an idea whose time has come. Archives of General Psychiatry 52: 200-202, 1995
16. Van Putten T, Crumpton E, Yale C: Drug refusal in schizophrenia and the wish to be crazy. Archives of General Psychiatry 33: 1443-1446, 1976
17. Harding CM, Brooks GW, Ashikaga T, et al: The Vermont longitudinal study of persons with severe mental illness. I: methodology, study sample, and overall status 32 years later. American Journal of Psychiatry 144:718-726, 1987
18. Carpenter WT, Tamminga CA: Why neuroleptic withdrawal in schizophrenia? Archives of General Psychiatry 52:192-193, 1995
19. Wyatt RJ: Risks of withdrawing antipsychotic medications. Archives of General Psychiatry 52:205-208, 1995
20. Stovall J: Is assertive community treatment ethical care? Harvard Review of Psychiatry 9:139-143, 2001